Barclays’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-44,072
| Closed | -$4.19M | – | 5853 |
|
|
2021
Q4 | $4.19M | Buy |
44,072
+2,060
| +5% | +$195K | ﹤0.01% | 1839 |
|
|
2021
Q3 | $3.97M | Buy |
42,012
+6,625
| +19% | +$626K | ﹤0.01% | 1781 |
|
|
2021
Q2 | $3.33M | Sell |
35,387
-17,050
| -33% | -$1.61M | ﹤0.01% | 1846 |
|
|
2021
Q1 | $4.89M | Buy |
52,437
+26,179
| +100% | +$2.45M | ﹤0.01% | 1539 |
|
|
2020
Q4 | $2.17M | Sell |
26,258
-1,650
| -6% | -$131K | ﹤0.01% | 2173 |
|
|
2020
Q3 | $2.12M | Buy |
27,908
+7,033
| +34% | +$522K | ﹤0.01% | 2046 |
|
|
2020
Q2 | $1.52M | Buy |
20,875
+2,138
| +11% | +$137K | ﹤0.01% | 2375 |
|
|
2020
Q1 | $902K | Sell |
18,737
-22,164
| -54% | -$1.43M | ﹤0.01% | 3059 |
|
|
2019
Q4 | $3.2M | Buy |
40,901
+15,184
| +59% | +$1.07M | ﹤0.01% | 2485 |
|
|
2019
Q3 | $1.6M | Sell |
25,717
-8,853
| -26% | -$590K | ﹤0.01% | 3142 |
|
|
2019
Q2 | $2.57M | Buy |
34,570
+11,142
| +48% | +$749K | ﹤0.01% | 2624 |
|
|
2019
Q1 | $1.55M | Buy |
23,428
+12,313
| +111% | +$790K | ﹤0.01% | 2884 |
|
|
2018
Q4 | $632K | Sell |
11,115
-47,687
| -81% | -$2.94M | ﹤0.01% | 3592 |
|
|
2018
Q3 | $4.24M | Buy |
58,802
+43,446
| +283% | +$3.5M | ﹤0.01% | 1985 |
|
|
2018
Q2 | $1.47M | Sell |
15,356
-33,980
| -69% | -$3.26M | ﹤0.01% | 2862 |
|
|
2018
Q1 | $5.28M | Buy |
49,336
+18,057
| +58% | +$1.81M | ﹤0.01% | 1595 |
|
|
2017
Q4 | $3.02M | Buy |
31,279
+12,621
| +68% | +$1.12M | ﹤0.01% | 2064 |
|
|
2017
Q3 | $1.61M | Sell |
18,658
-6,941
| -27% | -$547K | ﹤0.01% | 2550 |
|
|
2017
Q2 | $1.86M | Buy |
25,599
+7,794
| +44% | +$548K | ﹤0.01% | 2322 |
|
|
2017
Q1 | $1.23M | Sell |
17,805
-4,236
| -19% | -$309K | ﹤0.01% | 2549 |
|
|
2016
Q4 | $1.66M | Sell |
22,041
-8,314
| -27% | -$532K | ﹤0.01% | 2282 |
|
|
2016
Q3 | $1.63M | Sell |
30,355
-33,621
| -53% | -$2.03M | ﹤0.01% | 2162 |
|
|
2016
Q2 | $4.21M | Buy |
63,976
+16,558
| +35% | +$1.11M | 0.01% | 1445 |
|
|
2016
Q1 | $3.18M | Buy |
47,418
+43,818
| +1,217% | +$2.64M | ﹤0.01% | 1544 |
|
|
2015
Q4 | $220K | Buy |
3,600
+3,393
| +1,639% | +$182K | ﹤0.01% | 3834 |
|
|
2015
Q3 | $12K | Sell |
207
-876
| -81% | -$53K | ﹤0.01% | 5720 |
|
|
2015
Q2 | $76K | Sell |
1,083
-4,121
| -79% | -$280K | ﹤0.01% | 4874 |
|
|
2015
Q1 | $364K | Buy |
5,204
+229
| +5% | +$14.4K | ﹤0.01% | 3887 |
|
|
2014
Q4 | $299K | Sell |
4,975
-3,980
| -44% | -$235K | ﹤0.01% | 4316 |
|
|
2014
Q3 | $483K | Sell |
8,955
-237
| -3% | -$13.6K | ﹤0.01% | 3979 |
|
|
2014
Q2 | $570K | Sell |
9,192
-31,085
| -77% | -$1.83M | ﹤0.01% | 3845 |
|
|
2014
Q1 | $2.38M | Buy |
40,277
+23,998
| +147% | +$1.43M | ﹤0.01% | 2376 |
|
|
2013
Q4 | $961K | Sell |
16,279
-10,347
| -39% | -$618K | ﹤0.01% | 3445 |
|
|
2013
Q3 | $1.57M | Sell |
26,626
-12,610
| -32% | -$731K | ﹤0.01% | 2856 |
|
|
2013
Q2 | $2.2M | Buy |
+39,236
| New | +$2.05M | ﹤0.01% | 2445 |
|
Barclays's MGLN Position: Q1 2022 in Review
Barclays sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 44,072 shares — an estimated $4.19M sold.
Barclays first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $5.28M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- Barclays reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- Barclays sold 44,072 Magellan Health Services, Inc. shares in Q1 2022, an estimated $4.19M.
- Barclays first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- Barclays's Magellan Health Services, Inc. position peaked at $5.28M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.